These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Future trends of selenium in clinical applications. Wendel A Biomed Environ Sci; 1997 Sep; 10(2-3):359-62. PubMed ID: 9315331 [No Abstract] [Full Text] [Related]
43. Selenium in uremia: culprit or bystander? Bonomini M; Mujais SK; Ivanovich P; Klinkmann H Nephron; 1992; 60(4):385-9. PubMed ID: 1584313 [No Abstract] [Full Text] [Related]
44. [Use of selenium sulfide in blepharitis squamosa]. QUINTIERI C Boll Ocul; 1955 Nov; 34(11):687-92. PubMed ID: 13304180 [No Abstract] [Full Text] [Related]
45. Investigation of the biochemical and histopathological effects of vitamin C, selenium, and therapeutic ultrasound on muscle damage in rats. Tülüce Y; Tat NM; Kara M; Tat AM Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3581-3593. PubMed ID: 37261476 [TBL] [Abstract][Full Text] [Related]
46. Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range. Kobayashi Y; Ogra Y; Ishiwata K; Takayama H; Aimi N; Suzuki KT Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15932-6. PubMed ID: 12441402 [TBL] [Abstract][Full Text] [Related]
47. Selenium-based antihypertensives. Rationale and potential. May SW; Pollock SH Drugs; 1998 Dec; 56(6):959-64. PubMed ID: 9878985 [TBL] [Abstract][Full Text] [Related]
48. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Parnham MJ; Graf E Biochem Pharmacol; 1987 Oct; 36(19):3095-102. PubMed ID: 3311047 [No Abstract] [Full Text] [Related]
49. The pharmacology of ebselen. Parnham MJ; Leyck S; Graf E; Dowling EJ; Blake DR Agents Actions; 1991 Jan; 32(1-2):4-9. PubMed ID: 2058468 [No Abstract] [Full Text] [Related]
50. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds. Mishra B; Priyadarsini KI; Mohan H; Mugesh G Bioorg Med Chem Lett; 2006 Oct; 16(20):5334-8. PubMed ID: 16919452 [TBL] [Abstract][Full Text] [Related]
51. Effect of substituents on the GPx-like activity of ebselen: steric versus electronic. Pearson JK; Boyd RJ J Phys Chem A; 2008 Feb; 112(5):1013-7. PubMed ID: 18197644 [TBL] [Abstract][Full Text] [Related]
52. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions. Sarma BK; Mugesh G J Am Chem Soc; 2005 Aug; 127(32):11477-85. PubMed ID: 16089478 [TBL] [Abstract][Full Text] [Related]
53. Selenium: nutritional implications and prospects for therapeutic medicine. Fox JM Methods Find Exp Clin Pharmacol; 1992 May; 14(4):275-87. PubMed ID: 1507930 [No Abstract] [Full Text] [Related]